Showing results (891-900 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|December 23, 2006
A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinomaYing-Hua Lan, Yong-Guo Li, Zeng-Wei Liang, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cellsM R Young, M A Wright, M E Young
Cancer Immunology, Immunotherapy : CII|November 30, 2006
International meeting "Immunotherapy of cancer: challenges and needs"Maria Ferrantini, Imerio Capone, Francesco M Marincola, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2006
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccinesReshma Singh, Yvonne Paterson
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variantS P Cole, B M Campigotto, J G Johnson, et al.
Cancer Immunology, Immunotherapy : CII|December 13, 2006
Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectumGuanglin Cui, Rasmus Goll, Trine Olsen, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2006
The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGbeta by DNA immunizationQing Dong Guan, Ying Wang, Yi Wei Chu, et al.
Cancer Immunology, Immunotherapy : CII|December 11, 2008
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccinesAnn Mander, Ferdousi Chowdhury, Lindsey Low, et al.
Cancer Immunology, Immunotherapy : CII|December 5, 2008
TGF-alpha as a candidate tumor antigen for renal cell carcinomasSandy Pelletier, Simon Tanguay, Stephen Lee, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genesT Itaya, E Fearon, T Fiesinger, et al.
Pageof 650